Drug use by the elderly in Italy

Annals of Pharmacotherapy

Volumn 31, Issue 4, 1997, Pages 416-422

  Nobili, Alessandro ^a   Tettamanti, Mauro ^a   Frattura, Lucilla ^a   Spagnoli, Alberto ^a   Ferraro, Lorenza ^b   Marrazzo, Eleonora ^b   Ostino, Giuseppe ^b   Comelli, Mario ^c  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Serv Farmaceutico Unita Socio S   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIULCER AGENT; BENDAZAC LYSINE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUFLOMEDIL; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARDIOVASCULAR AGENT; CATALIN; CITICOLINE; DICLOFENAC; DIGOXIN; DIHYDROERGOTOXINE MESILATE; DIPYRIDAMOLE; DIURETIC AGENT; FUROSEMIDE; GASTROINTESTINAL AGENT; INDOBUFEN; LORAZEPAM; NICERGOLINE; NIFEDIPINE; NIMODIPINE; PIROXICAM; RANITIDINE; SALCATONIN; UNINDEXED DRUG; VERAPAMIL;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CATARACT; CEREBROVASCULAR DISEASE; DIGESTIVE SYSTEM DISEASE; DRUG EFFICACY; DRUG USE; GERIATRIC PATIENT; HEALTH CARE POLICY; HUMAN; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MENTAL DISEASE; MUSCULOSKELETAL DISEASE; PRIORITY JOURNAL; THROMBOEMBOLISM;

EID: 0031004315     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100405     Document Type: Article

References (32)

1. Stewart RB, Moore MT, May FE, Marks RG, Hale WE. A longitudinal evaluation of drug use in an ambulatory elderly population. J Clin Epidemiol 1991;44:1353-9.
2. Osterlind PO, Bucht G. Drug consumption during the last decade among persons born in 1902 in Umea, Sweden. Drugs Aging 1991;1:477-86.
3. Jylha M. Ten-year change in the use of medical drugs among the elderly. A longitudinal study and cohort comparison. J Clin Epidemiol 1994;47:69-79.
4. Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in the elderly. N Engl J Med 1989;321:303-9.
5. Ouslander JG. Drug therapy in the elderly. Ann Intern Med 1981;95:711-22.
6. Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994;272:292-6.
7. Kroenke K, Pinholt EM. Reducing polypharmacy in the elderly. A controlled trial of physician feedback. J Am Geriatr Soc 1990;38:31-6.
8. Beers MH, Ouslander JG. Risk factors in geriatric drug prescribing. A practical guide to avoiding problems. Drugs 1989;37:105-12.
9. Jörgensen TM, Isacson DGL, Thorslund M. Prescription drug use among ambulatory elderly in a Swedish municipality. Ann Pharmacother 1993;27:1120-5.
10. Helling DK, Lemke JH, Semla TP, Wallace RB, Lipson DP, Cornoni-Huntley J. Medication use characteristics in the elderly. The Iowa 65+ Rural Health Study. J Am Geriatr Soc 1987;4:4-12.
11. Laukkanen P, Heikkinen E, Kauppinen M, Kallinen M. Use of drugs by non-institutionalised urban Finns born in 1904-1923 and the association of drug use with mood and self-rated health. Age Ageing 1992;21:343-52.
12. Stewart RB, Moore MT, May FE, Marks RG, Hale WE. Changing pattern of therapeutic agents in the elderly: a ten year overview. Age Ageing 1991;20:182-8.
13. Weedle PB, Poston JW, Parish PA. Drug prescribing in residential homes for elderly people in the United Kingdom. Ann Pharmacother 1990;24:533-6.
14. Fillenbaum GG, Hanlon JT, Corder EH, Ziqubu-Page T, Wall WE Jr, Brook D. Prescription and non-prescription drug use among black and white community-residing elderly. Am J Public Health 1993;83:1577-82.
15. Delafuente JC, Meuleman JR, Conlin M, Hoffman NB, Lowenthal DT. Drug use among functionally active, aged, ambulatory people. Ann Pharmacother 1992;26:179-83.
16. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological psychosocial function. JAMA 1963;185:914-9.
17. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-86.
18. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
19. Spagnoli A, Foresti G, MacDonald A, Hugh PR. Italian version of the organic brain syndrome and the depression scales from the CARE: evaluation of their performance in geriatric institutions. Psychol Med 1987;17:507-13.
20. Classificazionedelle malattie, traumatismi e cause di morte. IX Revisione - 1975 Rome, Italy: Istituto Centrale di Statistics 1984.
21. Nordic statistic on medicines. Guidelines for ATC classification. 1987-1989. Uppsala, Sweden 1990.
22. SAS Version 6.0.7. Cary, NC: SAS Institute National Inc., 1995.
23. Chinburapa V, Larson LN, Brucks M, Draugalis J, Bootman JL, Puto CP. Physician prescribing decision: the effects of situational involvement and task complexity on information acquisition and decision making. Soc Sci Med 1993;36:1473-82.
24. Law R, Chalmers C. Medicines and elderly people: a general practice survey. Br Med J 1976;281:565-8.
25. Spagnoli A, Menasce G. I farmaci "cerebroattivi." Ricerca e Pratica 1986;10:72-8.
26. Colley CA, Lucas LM. Polypharmacy: the cure becomes the disease. J Gen Intern Med 1993;8:278-83.
27. Hale WE, May FE, Marks RG, Stewart RB. Drug use in an ambulatory elderly population: a five-year update. Drug Intell Clin Pharm 1987;21:530-5.
28. Ostrom JR, Hammarlund ER, Christensen DB, Plein JB, Kethly AJ. Medication usage in an elderly population. Med Care 1985;23:157-64.
29. Stuart B, Coulson NE. Dynamic aspect of prescription drug use in an elderly population. Health Serv Res 1993;28:237-64.
30. Kotzan L, Carrol NV, Kotzan JA. Influence of age, sex, and race on prescription drug use among Georgia Medicaid recipients. Am J Hosp Pharm 1989;46:287-90.
31. Spagnoli A, Forloni G, Furlanetto M, Lucca U, Tettamanti M, Tiraboschi P. Psicofarmaci e anziani. In: Bellantuono C, Tansella M, eds. Gli psicofarmaci nella pratica terapeutica. Terza Edizione. Roma Il Pensiero Scientifico Editore, 1993:569-630.
32. Garattini S. Cultural shift in Italy's drug policy. Lancet 1995;346:5-6.